Phase 2 Study of Oral AB1010 in Non Pre-treated, Inoperable Patients With Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2012
At a glance
- Drugs Masitinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 19 Sep 2012 Planned End Date changed from 1 Jan 2011 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 05 Jun 2012 Five-year follow-up results have been presented at ASCO-2012 according to an AB Science media release. Results were also reported in the media release.
- 30 Oct 2009 New trial record